898.7500 11.40 (1.28%)
NSE Jun 27, 2025 15:31 PM
Volume: 668.4K
 

898.75
1.28%
Geojit BNP Paribas
We upgrade our rating to Accumulate based on 10x FY22 EPS with a target of price of Rs.485 as new launches in U.S and other regulated markets will drive growth. Revenues were down 26% yoy and down 16% qoq mainly on...
Strides Pharma Science Ltd. has gained 34.30% in the last 3 Months
More from Strides Pharma Science Ltd.
Recommended